Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356349/
https://www.ncbi.nlm.nih.gov/pubmed/37476808
http://dx.doi.org/10.1155/2023/9812975
_version_ 1785075250852003840
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10356349
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103563492023-07-20 Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356349/ /pubmed/37476808 http://dx.doi.org/10.1155/2023/9812975 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title_full Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title_fullStr Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title_full_unstemmed Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title_short Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
title_sort retracted: the application of targeted nanodrugs with dual responsiveness of ph and ros in preventing and treating vascular restenosis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356349/
https://www.ncbi.nlm.nih.gov/pubmed/37476808
http://dx.doi.org/10.1155/2023/9812975
work_keys_str_mv AT healthcareengineeringjournalof retractedtheapplicationoftargetednanodrugswithdualresponsivenessofphandrosinpreventingandtreatingvascularrestenosis

Ejemplares similares